✦ LIBER ✦

Economic costs of chemotherapy-induced febrile neutropenia among patients with non-Hodgkin’s lymphoma in European and Australian clinical practice

✍ Scribed by Derek Weycker, Aurelie Danel, Anne Marciniak, Kate Bendall, Michael Lipsitz, Ruth Pettengell

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PSY19 Economic Costs of Chemotherapy-Ind

✍ D. Weycker; A. Danel; A. Marciniak; K. Bendall; M. Lipsitz; R. Pettengell 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Multivariate analysis of febrile neutrop

✍ Ruth Pettengell; André Bosly; Thomas D. Szucs; Christian Jackisch; Robert Leonar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

PCN10 ESTIMATION OF G-CSF EFFECTIVENESS

✍ X Pan; J Brooks 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Cost benefit and clinical efficacy of lo

✍ S. HASHINO; M. MORIOKA; T. IRIE; N. SHIROSHITA; T. KAWAMURA; S. SUZUKI; H. IWASA 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

PCN88 Economic Model of Granulocyte-Colo

✍ Perrier, L.; Sebban, C.; Leon, N.; Maurel, F.; Cohen-Nizard, S.; De Liège, F. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

The Impact of Age on Delivered Dose Inte

✍ Morrison, Vicki A.; Picozzi, Vincent; Scott, Shane; Pohlman, Brad; Dickman, Elli 📂 Article 📅 2001 🏛 CIG Media Group, LP. 🌐 English ⚖ 160 KB